Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FDG | 108.80 | 1.39 | +1.30% |
| American Century Foc Dynmc Gr ETF | |||
| OUSA | 53.61 | 0.33 | +0.62% |
| ALPS O'Shares US Quality Div ETF | |||
| VIOO | 101.39 | 0.25 | +0.25% |
| Vanguard S&P Small-Cap 600 ETF | |||
| AOHY | 11.16 | 0.01 | +0.04% |
| Angel Oak High Yield Opportunities ETF | |||
| MSOX | 2.45 | -0.09 | -3.54% |
| AdvisorShares MSOS Daily Leveraged ETF | |||
A.I.dvisor tells us that INNMF and BIVI have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INNMF and BIVI's prices will move in lockstep.
| Ticker / NAME | Correlation To INNMF | 1D Price Change % | ||
|---|---|---|---|---|
| INNMF | 100% | +61.64% | ||
| BIVI - INNMF | 26% Poorly correlated | -1.94% | ||
| HOFBF - INNMF | 23% Poorly correlated | N/A | ||
| CYTK - INNMF | 23% Poorly correlated | -2.21% | ||
| PHRRF - INNMF | 20% Poorly correlated | +20.31% | ||
| IVEVF - INNMF | 15% Poorly correlated | N/A | ||
More | ||||